Consolidated Portfolio Review Corp’s Oracle ORCL Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,988	Closed	-$1.4M	–	277
2025 Q3	$1.4M	Buy	4,988 +50	+1%	+$12.7K	0.18%	135
2025 Q2	$1.08M	Sell	4,938 -62	-1%	-$10K	0.15%	149
2025 Q1	$699K	Buy	5,000 +38	+0.8%	+$6.19K	0.11%	187
2024 Q4	$827K	Buy	4,962 +1,841	+59%	+$327K	0.13%	174
2024 Q3	$532K	Sell	3,121 -80	-2%	-$11.6K	0.12%	183
2024 Q2	$452K	Buy	3,201 +1,484	+86%	+$184K	0.11%	188
2024 Q1	$216K	Sell	1,717 -2,895	-63%	-$331K	0.06%	251
2023 Q4	$486K	Sell	4,612 -229	-5%	-$25K	0.11%	175
2023 Q3	$513K	Buy	4,841 +141	+3%	+$16.3K	0.12%	168
2023 Q2	$560K	Sell	4,700 -129	-3%	-$13.3K	0.13%	157
2023 Q1	$449K	Buy	+4,829	New	+$423K	0.12%	169

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Consolidated Portfolio Review Corp's ORCL Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Oracle (ORCL) in Q4 2025, closing a stake of 4,988 shares — an estimated $1.4M sold.

Consolidated Portfolio Review Corp first reported a position in ORCL in Q1 2023 and held it in 11 quarters. The position peaked at $1.4M in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 4,988 Oracle shares in Q4 2025, an estimated $1.4M.
Consolidated Portfolio Review Corp first reported a position in Oracle in Q1 2023 and held it in 11 quarters.
Consolidated Portfolio Review Corp's Oracle position peaked at $1.4M in Q3 2025.
3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.